(lp0
S'Interpace Diagnostics Group, Inc.  Gets Sell-Side Rating and ... StockNewsUnion - 12 hours ago Interpace Diagnostics Group, Inc.  shares are up over 15% at $2.82. Volumes are heavy - over 8.9 million shares have traded as of 1 PM EST.Interpace Diagnostics Group, Inc.  held by 3 SEC 13F Filers - Post AnalystZooming In On The Trending Stocks- Interpace Diagnostics Group Inc '
p1
aS'Interpace Diagnostics Announces Agreement with Blue Cross Blue Shield (BCBS ... PR Newswire  - Jan 3, 2017 PARSIPPANY, N.J., Jan. 3, 2017 /PRNewswire/ -- Interpace Diagnostics Corp. , a company that provides clinically useful molecular diagnostic tests and pathology services for evaluating risks of cancer, announced today that the Company&nbsp;...'
p2
aS'Interpace Diagnostics to Present New Data on Thyroid Product Performance PR Newswire  - Feb 27, 2017 27, 2017 /PRNewswire/ -- Interpace Diagnostics Group, Inc. , a fully integrated commercial company that provides clinically useful molecular diagnostic tests and pathology services, announced today the acceptance of four posters to be&nbsp;...'
p3
aS'Interpace Diagnostics Participates in USA Today Endocrine Health Campaign Yahoo Finance - Mar 20, 2017 PARSIPPANY, N.J., March 20, 2017 /PRNewswire/ -- Interpace Diagnostics Group, Inc. , a fully integrated commercial company that provides clinically useful molecular diagnostic tests and pathology services, today announced its participation in a&nbsp;...'
p4
aS'Interpace Diagnostics Group Announces 1-for-10 Reverse Split PR Newswire  - Dec 28, 2016 PARSIPPANY, N.J., Dec. 28, 2016 /PRNewswire/ -- Interpace Diagnostics Group, Inc.  , a company that provides clinically useful molecular diagnostic tests and pathology services for evaluating ...Services Stocks Worth Chasing: JC Penney Company, Inc. , Interpace ... - The Independent Republic'
p5
aS'Interpace Diagnostics Announces New Aetna Coverage Policy PR Newswire  - Dec 8, 2016 PARSIPPANY, N.J., Dec. 8, 2016 /PRNewswire/ -- Interpace Diagnostics Corp. , a company that provides clinically useful molecular diagnostic tests and pathology services, announced today that Aetna, the third largest health plan in the&nbsp;...'
p6
aS'Interpace Diagnostics Group Inc  Jumps 9.87% For the Week Business Review - 18 hours ago Pushing higher over the last five sessions are shares of Interpace Diagnostics Group Inc . The stock has risen 9.87% over that span, yielding profits for savvy traders.'
p7
aS'Interpace Diagnostics Announces New York State Approval of ThyGenX for ... PR Newswire  - Oct 5, 2016 PARSIPPANY, N.J., Oct. 5, 2016 /PRNewswire/ -- Interpace Diagnostics Corp. , a company that provides specialized molecular diagnostic tests and pathology services, announced today that the New York State Department of Health has&nbsp;...'
p8
aS'Brokerage Expectations in Spotlight For Interpace Diagnostics Group, Inc ... Rives Journal - 15 hours ago Sell-side analysts are offering a consensus Buy rating on shares of Interpace Diagnostics Group, Inc. . Using the following ratings scale: 1.0 Strong Buy, 2.0 Buy, 3.0 Hold, 4.0 Sell and 5.0 Strong Sell, analysts have an average recommendation ...'
p9
aS'Company Update : Interpace Diagnostics Group Inc Investors ... Smarter Analyst - Jan 20, 2017 Shareholders in Interpace Diagnostics Group Inc  have a reason to celebrate today after the company announced that it has entered in to an agreement with Best Med Opinion Ltd of Tel Aviv, Israel, a provider of second opinion and clinical&nbsp;...Interpace inks deal with treatment advisor to provide tests; shares up 30% - Seeking Alpha'
p10
a.